Dasatinib Tablet is indicated for the treatment of newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in chronic phase, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy, including imatinib.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/UC2Bt0v
via IFTTT
0 comments:
Post a Comment